Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hormone therapy in gender dysphoria
2019-000300-16Phase 3Active
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- Aug 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of testosterone enanthate and estradiol in gender dysphoria (GD), sponsored by Assistance publique - Hôpitaux de Paris. Started Aug 2020; status: active.
02
Drugs
testosterone enanthateestradiol
03
Conditions
gender dysphoria (GD)
Beyond the preview
Go deeper on 2019-000300-16.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2019-000300-16.